About the Authors

Simon Lebek

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Philipp Hegner

Roles Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Christian Schach

Roles Conceptualization, Data curation, Investigation, Methodology, Resources

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Kathrin Reuthner

Roles Data curation, Formal analysis, Investigation, Methodology

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Maria Tafelmeier

Roles Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Lars Siegfried Maier

Roles Conceptualization, Funding acquisition, Project administration, Resources, Software, Supervision, Writing – review & editing

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Michael Arzt

Roles Conceptualization, Funding acquisition, Resources, Supervision, Validation, Writing – review & editing

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Stefan Wagner

Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing

stefan.wagner@ukr.de

Affiliation Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

Competing Interests

MA received grant support from ResMed, the ResMed Foundation, and Philips Respironics as well as lecture and consulting fees from ResMed, Philips Respironics, Boehringer-Ingelheim, NRI, Novartis and Bresotec. There are no other competing interests to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.